2141 related articles for article (PubMed ID: 7599772)
21. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
22. [Rational evaluation of different lymph node dissection].
Chen JQ; Wang SB; Qi CL
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
[TBL] [Abstract][Full Text] [Related]
23. Biologic predictors of survival in node-negative gastric cancer.
Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
[TBL] [Abstract][Full Text] [Related]
24. [Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study].
Roviello F; Marrelli D; Morgagni P; De Manzoni G; Di Leo A; Vindigni C; Nastri G; Saragoni L; Tomezzoli A; Kurihara H; De Stefano A
Chir Ital; 2003; 55(4):491-8. PubMed ID: 12938593
[TBL] [Abstract][Full Text] [Related]
25. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
26. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach.
Abe S; Yoshimura H; Nagaoka S; Monden N; Kinugasa S; Nagasue N; Nakamura T
J Am Coll Surg; 1995 Nov; 181(5):389-96. PubMed ID: 7582205
[TBL] [Abstract][Full Text] [Related]
28. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma.
Kato M; Saji S; Kawaguchi Y; Kunieda K; Sugiyama Y; Takagi Y; Hiraoka T; Kumazawa I; Adachi T
Hepatogastroenterology; 1999; 46(30):3281-6. PubMed ID: 10626202
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
32. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathologic features of early gastric cancer in elderly patients.
Ishigami S; Natsugoe S; Saihara T; Hokita S; Tokushige M; Watanabe T; Iwaschige H; Aikou T
Hepatogastroenterology; 1997; 44(16):1164-8. PubMed ID: 9261618
[TBL] [Abstract][Full Text] [Related]
34. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
35. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
37. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
39. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
40. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
